4.0 Letter

Safety and efficacy of COVID-19 convalescent plasma in severe pulmonary disease: A report of 17 patients

Related references

Note: Only part of the references are listed.
Article Biophysics

Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis

Zhen Huang et al.

BIOSENSORS & BIOELECTRONICS (2020)

Article Medicine, General & Internal

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

Chenguang Shen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Virology

Treatment with convalescent plasma for COVID-19 patients in Wuhan, China

Mingxiang Ye et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Biochemistry & Molecular Biology

Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study

Sean T. H. Liu et al.

NATURE MEDICINE (2020)

Review Immunology

History of passive antibody administration for prevention and treatment of infectious diseases

Barney S. Graham et al.

CURRENT OPINION IN HIV AND AIDS (2015)

Article Infectious Diseases

Use of convalescent plasma therapy in SARS patients in Hong Kong

Y Cheng et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)